The San Francisco-based firm will use the proceeds to accelerate commercialization of its Intellisep rapid sepsis test.

The governmental funding will support the company's plans for a 1,350 participant trial that aims to further validate its protein-based cancer early detection assay.

NowDx's First to Know Syphilis Test received FDA authorization in August, making it the first over-the-counter syphilis test to be authorized by the agency.

Deck: Xgenera has also closed a round of seed financing worth £500,000 and commenced a partnership with YouSeq, a UK technology firm.

The Maryland-based firm reported in a recent proof-of-concept study that It used protease biomarkers to identify patients ...

The round, which was led by Formation Venture Engineering, will support commercialization of the company's SAAmplify-ɑSYN biomarker test as well as increased R&D.

The US Food and Drug Administration granted marketing clearances for multiple infectious disease tests and a blood culture sample preparation system, among other devices.

The agreement's goal is to bring a blood-based test to market to stratify patients with traumatic brain injuries.

CyPath Lung is a laboratory-developed assay that uses self-collected sputum samples treated with a fluorescent compound that preferentially binds to cancer cells and cancer-related cells, San ...

Tests for SphingoTec's penKid biomarker of acute kidney injury will become available to central labs through Beckman Coulter's Access instruments.

The company has developed a blood-based test to assess whether women are carriers of the antibodies that cause maternal autoantibody related-autism.